对急性乙型肝炎没有特定的治疗。
前言：目的：对促肝细胞生长素治疗急性乙型肝炎的疗效进行观察。
Objective: to observe the therapeutic effects of promoting hepatocyte growth factor (PHGF) on acute hepatitis b.
目的探讨急性乙型肝炎患者血清乙型肝炎病毒（HBV）清除及临床转归的机制。
ObjectiveTo study the mechanisms of the hepatitis B virus(HBV) clearance with clinical data.
急性乙型肝炎没有特异治疗方法。治疗的目的是让身体感到舒服和保持足够的营养平衡，包括补充因呕吐和腹泻流失的液体。
There is no specific treatment for acute hepatitis B. Care is aimed at maintaining comfort and adequate nutritional balance, including replacement of fluids that are lost from vomiting and diarrhoea.
估计每年有60万人死于急性或慢性乙型肝炎。
An estimated 600 000 persons die each year due to the acute or chronic consequences of hepatitis B.
然而乙型肝炎在临床上并不只是表现为急性经过。
The acute disease is not the only way that hepatitis B afflicts humans, however.
结论：与单纯感染相比，乙型肝炎多重感染肝功能损害严重，有重症化倾向，易急性发作。
Conclusions: the patient with multiple virus infections has more severe liver function injury and more opportunity to get acute attack compared with the single virus infection patient.
目的对比研究同一慢性乙型肝炎患者拉米夫定治疗前及病情急性恶化后乙型肝炎病毒（HBV）株的结构基因组。
Objective To compare the structural genome variations of lamivudine resistant HBV strain from a patient with acute exacerbation after lamivudine therapy with pretretment HBV strain.
目的对比研究同一慢性乙型肝炎患者拉米夫定治疗前及病情急性恶化后乙型肝炎病毒（HBV）株的结构基因组。
Objective To compare the structural genome variations of lamivudine resistant HBV strain from a patient with acute exacerbation after lamivudine therapy with pretretment HBV strain.
应用推荐